title: Lack of chondrogenic expression in mouse limb bud micromass cultures exposed to exogenous beta galactosidase or N-acetyl-beta-glucosaminidase.
abstract: The effect of two exoglycosidases, beta-galactosidase and N-acetyl-beta-glucosaminidase (GlcNAc-ase) on chondrogenic expression of stage 19 mouse limb bud micromass cultures was investigated. Chondrogenic expression was monitored by Alcian blue staining and immunofluorescent localization of cartilage-specific proteoglycan and type II collagen. Chondrogenesis was inhibited by exposure to 0.1 U/ml beta-galactosidase or 0.025 U/ml GlcNAc-ase for 24 h or longer in culture. The effect of both enzymes was concentration and time dependent. Exoglycosidic hydrolysis of galactose or N-acetylglucosamine was substantiated by treatment with HRP-conjugated peanut agglutinin and succinylated wheat germ agglutinin, respectively. Cells treated with beta-galactosidase appeared to be flattened with a stellate morphology, whereas GlcNAc-ase-treated cells were bipolar forming ridge-like mounds that had a directional orientation. The antichondrogenic effect was not alleviated when the cells were induced to assume a spherical shape upon treatment with cytochalasin D. DNA measurements indicated that the lack of chondrogenic expression was not related to cell attachment or cell proliferation. These data support the hypothesis that the expression of specific terminal sugars on cell surface glycoconjugates of limb bud cells represents an important component of the chondrogenic process.
authors.affiliation: Department of Biology, Emory University Atlanta, Georgia 30322.
authors.forename: W A
authors.initials: WA
authors.lastname: Elmer
authors.forename: S
authors.initials: S
authors.lastname: Pollard
authors.forename: J D
authors.initials: JD
authors.lastname: Cochran
mesh_terms: D000118:Acetylglucosaminidase / Q000494:pharmacology*; D000818:Animals; D002356:Cartilage / Q000166:cytology*; D002454:Cell Differentiation / Q000187:drug effects; D003094:Collagen / Q000378:metabolism; D015638:Cytochalasin D / Q000494:pharmacology; D004247:DNA / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005121:Extremities / Q000196:embryology*; D037102:Lectins / Q000494:pharmacology; D051379:Mice; D009924:Organ Culture Techniques; D019887:Peanut Agglutinin; D011509:Proteoglycans / Q000378:metabolism; D013997:Time Factors; D014909:Wheat Germ Agglutinins / Q000494:pharmacology; D001616:beta-Galactosidase / Q000494:pharmacology*
chemical_list: D037102:Lectins; D019887:Peanut Agglutinin; D011509:Proteoglycans; D014909:Wheat Germ Agglutinins; D015638:Cytochalasin D; D003094:Collagen; D004247:DNA; D001616:beta-Galactosidase; D000118:Acetylglucosaminidase